Chemotherapy Induced Neuropathy in Cancer Patients
Recruiting
Observational Study
Chemotherapy-induced Peripheral Neuropathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 124 (estimated)
- Sponsor
- Swami Rama Himalayan University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this prospective study is to perform Nerve conduction test, Vitamin D, Vitamin B12 and NADPH oxidase 4(NOX4) expression to assess severity of chemotherapy induced Peripheral neuropathy (CIPN) in solid cancer (Head and Neck, Breast, Prostate) patients who planned for at least 4 cycle of chemotherapy in different nutrient status level and gene expression.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All patients receiving chemotherapy for solid cancer
* Patient aged\>18years
Exclusion Criteria:
* Age ≤ 18 years
* Pre-existing neuropathy
* Patients diagnosed with Psychiatric illness
* Patients with pre-existing peripheral neuropathy
* Patients taking medication for neuro…
Contacts
No contact information available.